ONC 113 B
Alternative Names: ONC 1-13B; ONC-10013BLatest Information Update: 28 Jul 2018
Price :
$50 *
At a glance
- Originator AllaChem
- Developer AllaChem; Avionco
- Class Antiandrogens; Antineoplastics; Small molecules; Urea compounds
- Mechanism of Action Androgen receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Breast cancer; Prostate cancer
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for phase-I development in Prostate-cancer(Hormone refractory, Late-stage disease, Metastatic disease) in Russia (PO)
- 28 Jul 2018 No recent reports of development identified for preclinical development in Breast-cancer in Russia (PO)
- 03 Apr 2017 Chemical structure information added